Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.

Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, Brown NJ, Reed MW.

BMC Cancer. 2006 Jul 14;6:188.

2.

Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.

Enjuanes A, Benavente Y, Hernández-Rodríguez J, Queralt C, Yagüe J, Jares P, de Sanjosé S, Campo E, Cid MC.

Rheumatology (Oxford). 2012 May;51(5):841-51. doi: 10.1093/rheumatology/ker429. Epub 2012 Jan 17.

PMID:
22258388
3.

Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Slattery ML, Herrick JS, Torres-Mejia G, John EM, Giuliano AR, Hines LM, Stern MC, Baumgartner KB, Presson AP, Wolff RK.

Carcinogenesis. 2014 Aug;35(8):1750-9. doi: 10.1093/carcin/bgu078. Epub 2014 Mar 26.

4.

Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women.

Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, Heinze G, Reinthaller A, Tong-Cacsire D, Tempfer C, Zeillinger R.

Clin Cancer Res. 2005 Aug 15;11(16):5718-21.

5.

Polymorphisms of the IL12B, IL1B, and TNFA genes and susceptibility to asthma.

Padrón-Morales J, Sanz C, Dávila I, Muñoz-Bellido F, Lorente F, Isidoro-García M.

J Investig Allergol Clin Immunol. 2013;23(7):487-94.

6.

Endostatin gene variation and protein levels in breast cancer susceptibility and severity.

Balasubramanian SP, Cross SS, Globe J, Cox A, Brown NJ, Reed MW.

BMC Cancer. 2007 Jun 22;7:107.

7.

Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.

Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P.

Hematol Oncol. 2008 Jun;26(2):98-103. doi: 10.1002/hon.843.

PMID:
18271063
8.

MDR1 C3435T polymorphism in patients with breast cancer.

Turgut S, Yaren A, Kursunluoglu R, Turgut G.

Arch Med Res. 2007 Jul;38(5):539-44. Epub 2007 Apr 26.

PMID:
17560460
9.

Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.

Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, Chouchane L.

BMC Cancer. 2010 Jun 12;10:283. doi: 10.1186/1471-2407-10-283.

10.

The prognostic value of four interleukin-1 gene polymorphisms in Caucasian women with breast cancer: a multicenter study.

Grimm C, Kantelhardt E, Heinze G, Polterauer S, Zeillinger R, Kölbl H, Reinthaller A, Hefler L.

BMC Cancer. 2009 Mar 6;9:78. doi: 10.1186/1471-2407-9-78.

11.

Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.

Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW.

Breast Cancer Res. 2004;6(4):R395-400. Epub 2004 May 24.

12.

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

BMC Cancer. 2009 Sep 18;9:331. doi: 10.1186/1471-2407-9-331.

13.

Interleukin promoter polymorphisms and prognosis in colorectal cancer.

Wilkening S, Tavelin B, Canzian F, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P, Försti A.

Carcinogenesis. 2008 Jun;29(6):1202-6. doi: 10.1093/carcin/bgn101. Epub 2008 Apr 30.

PMID:
18448485
14.

Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.

Pooja S, Chaudhary P, Nayak LV, Rajender S, Saini KS, Deol D, Kumar S, Bid HK, Konwar R.

Cytokine. 2012 Oct;60(1):122-8. doi: 10.1016/j.cyto.2012.06.241. Epub 2012 Jul 18.

PMID:
22818022
15.

Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.

Smith KC, Bateman AC, Fussell HM, Howell WM.

Eur J Immunogenet. 2004 Aug;31(4):167-73.

PMID:
15265021
16.

Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.

Mattuzzi S, Barbi S, Carletto A, Ravagnani V, Moore PS, Bambara LM, Scarpa A.

J Rheumatol. 2007 May;34(5):997-1004. Epub 2007 Apr 15.

PMID:
17444587
17.

The role of polymorphisms in circadian pathway genes in breast tumorigenesis.

Dai H, Zhang L, Cao M, Song F, Zheng H, Zhu X, Wei Q, Zhang W, Chen K.

Breast Cancer Res Treat. 2011 Jun;127(2):531-40. doi: 10.1007/s10549-010-1231-2. Epub 2010 Oct 27.

PMID:
20978934
18.

Role of cytokine gene polymorphisms in gastric cancer risk in Chile.

Gonzalez-Hormazabal P, Musleh M, Bustamante M, Stambuk J, Escandar S, Valladares H, Lanzarini E, Chiong H, Rojas J, Castro VG, Rubio-Reyes C, Jara L, Berger Z.

Anticancer Res. 2014 Jul;34(7):3523-30.

PMID:
24982364
19.

Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata.

Redler S, Albert F, Brockschmidt FF, Herold C, Hanneken S, Eigelshoven S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC.

Br J Dermatol. 2012 Dec;167(6):1360-5. doi: 10.1111/bjd.12004. Epub 2012 Nov 20.

PMID:
22897480
20.

Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.

Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.

J Biomed Sci. 2006 May;13(3):419-32. Epub 2006 Feb 25.

PMID:
16502042

Supplemental Content

Support Center